Cargando…
Adverse Outcome Pathway Development for Assessment of Lung Carcinogenicity by Nanoparticles
Lung cancer, one of the most common and deadly forms of cancer, is in some cases associated with exposure to certain types of particles. With the rise of nanotechnology, there is concern that some engineered nanoparticles may be among such particles. In the absence of epidemiological evidence, asses...
Autores principales: | Nymark, Penny, Karlsson, Hanna L., Halappanavar, Sabina, Vogel, Ulla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915843/ https://www.ncbi.nlm.nih.gov/pubmed/35295099 http://dx.doi.org/10.3389/ftox.2021.653386 |
Ejemplares similares
-
Development of a data-driven approach to Adverse Outcome Pathway network generation: a case study on the EATS-modalities
por: Wiklund, Linus, et al.
Publicado: (2023) -
SciRAPnano: a pragmatic and harmonized approach for quality evaluation of in vitro toxicity data to support risk assessment of nanomaterials
por: Shao, Gen, et al.
Publicado: (2023) -
In silico approaches in carcinogenicity hazard assessment: case study of pregabalin, a nongenotoxic mouse carcinogen
por: Keller, Douglas A., et al.
Publicado: (2023) -
Primary and Secondary Genotoxicity of Nanoparticles: Establishing a Co-Culture Protocol for Assessing Micronucleus Using Flow Cytometry
por: Vallabani, N. V. Srikanth, et al.
Publicado: (2022) -
Integration of Adverse Outcome Pathways, Causal Networks and ‘Omics to Support Chemical Hazard Assessment
por: Perkins, Edward J., et al.
Publicado: (2022)